Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance

BACKGROUND: Neonatal sepsis is a serious bacterial infection of neonates, globally killing up to 680 000 babies annually. It is frequently complicated by antimicrobial resistance, particularly in low- and middle-income country (LMIC) settings with widespread resistance to the WHO’s recommended empir...

Descripción completa

Detalles Bibliográficos
Autores principales: Darlow, Christopher A., Farrington, Nicola, Johnson, Adam, McEntee, Laura, Unsworth, Jennifer, Jimenez-Valverde, Ana, Kolamunnage-Dona, Ruwanthi, Da Costa, Renata M A, Ellis, Sally, Franceschi, François, Sharland, Mike, Neely, Michael, Piddock, Laura J. V., Das, Shampa, Hope, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047679/
https://www.ncbi.nlm.nih.gov/pubmed/35170719
http://dx.doi.org/10.1093/jac/dkac038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047679/
https://www.ncbi.nlm.nih.gov/pubmed/35170719
http://dx.doi.org/10.1093/jac/dkac038

Ejemplares similares